查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1735840

全球大麻 CBD 市場規模研究（按最終用途、配銷通路和區域預測，2022-2032 年）

Global Hemp CBD Market Size study, by End Use, Distribution Channel, and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年全球大麻 CBD 市場價值約為 39.1 億美元，預計在 2024-2032 年預測期內將以超過 18.59% 的驚人複合年成長率成長。大麻二酚 (CBD) 是一種從大麻中提取的非精神活性化合物，已成為健康、製藥和營養保健品市場中最具顛覆性和變革性的力量之一。其受歡迎程度的飆升可以歸因於其廣泛的治療益處——從疼痛管理和抗炎特性到治療焦慮和失眠的功效——使其成為多個消費者群體青睞的替代品。隨著監管環境的變化和社會對大麻衍生物態度的緩和，大麻衍生的 CBD 產品已在主流零售通路站穩腳跟，推動了已開發經濟體和新興經濟體的需求。

大麻 CBD 市場的上升勢頭因多種宏觀經濟和行為變化的共同作用而得到加強。隨著人們對植物療法益處的認知不斷提高，加上對自然健康療法的傾向不斷增強，消費者的興趣也日益濃厚。此外，各司法管轄區內大麻種植的合法化刺激了供應鏈，為酊劑、外用藥、食品和個人護理用品等產品類別的創新打開了閘門。然而，市場仍在努力應對諸如監管框架不一致、缺乏標準化劑量方案以及品質控制挑戰等複雜問題。即便如此，製造商、研究機構和政府機構之間不斷增加的研發投入和策略合作正在積極解決這些障礙，為可擴展、合規的成長鋪平道路。

消費者的偏好變得越來越複雜，促使品牌提供多樣化的產品並增強交付方式。從水溶性 CBD 飲料到吸收率更快的奈米乳化配方，創新競賽正在重新定義該領域的競爭優勢。此外，人們越來越注重功能性健康，注入 CBD 的產品現在已融入日常生活，例如皮膚護理、營養補充，甚至寵物護理。分銷管道也同步發展，電子商務平台在擴大覆蓋範圍方面發揮關鍵作用，而藥房、保健品商店和專賣店等實體店則透過店內教育和產品試用來增強消費者信任。

由於早期監管自由化、消費者意識高以及供應鏈基礎設施完善，北美在全球大麻 CBD 市場佔據主導地位。在新創公司、傳統健康品牌和積極的行銷活動的推動下，美國繼續在創新和採用方面處於領先地位。歐洲緊隨其後，成為有力的競爭者，得益於其注重健康的民眾、不斷進步的監管變化以及替代藥物支出的增加。亞太地區雖然相對新興，但由於合法化框架的擴大、可支配收入的增加以及中國、印度和日本等主要市場的消費者生活方式的改變，該地區正在經歷加速成長。拉丁美洲和中東及非洲正逐漸成為一個機會豐富的地區，特別是隨著政府啟動大麻改革和健康意識的提高。

目錄

第1章：全球工業大麻 CBD 市場執行摘要

  • 全球市場規模及預測（2022-2032）
  • 區域概要
  • 分段總結
    • 按最終用途
    • 按配銷通路
  • 主要趨勢
  • 經濟衰退的影響
  • 分析師建議與結論

第2章：全球大麻CBD市場定義與研究假設

  • 研究目標
  • 市場定義
  • 研究假設
    • 包容與排斥
    • 限制
    • 供給側分析
      • 種植和提取能力
      • 處理基礎設施
      • 監管環境
      • 市場競爭
      • 經濟可行性（生產者視角）
    • 需求面分析
      • 監理框架
      • 消費者認知與接受度
      • 配方技術進步
      • 健康與保健趨勢
  • 估算方法
  • 研究涵蓋的年份
  • 貨幣兌換率

第3章：全球大麻CBD市場動態

  • 市場促進因素
    • 擴大治療應用與健康應用
    • 大麻種植的合法化與管制自由化
    • 對天然植物性健康解決方案的需求激增
  • 市場挑戰
    • 不同地區的監管框架不一致
    • 品質控制和缺乏標準化劑量
    • 供應鏈複雜性和原料多變性
  • 市場機會
    • 遞送形式的創新（奈米乳液、水溶性混合物）
    • 電子商務和直接面對消費者的管道擴張
    • 新興市場的成長潛力

第4章：全球大麻CBD市場產業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭對手
    • 波特五力模型的未來主義方法
    • 五力影響分析
  • PESTEL分析
    • 政治的
    • 經濟的
    • 社會的
    • 科技
    • 環境的
    • 合法的
  • 最佳投資機會
  • 最佳獲勝策略
  • 顛覆性趨勢
  • 產業專家觀點
  • 分析師建議與結論

第5章：全球大麻 CBD 市場規模及預測：依最終用途分類，2022 年至 2032 年

  • 細分儀表板
  • 2022 年和 2032 年按最終用途分類的收入趨勢分析（百萬美元/十億美元）
    • 個人使用
    • 醫療用途
    • 健康與化妝品
    • 食品和飲料
    • 其他

第6章：全球大麻 CBD 市場規模及預測：依配銷通路分類，2022-2032 年

  • 細分儀表板
  • 2022 年和 2032 年按配銷通路分類的收入趨勢分析（百萬美元/十億美元）
    • 線上
    • 離線

第7章：全球大麻 CBD 市場規模及預測：按地區分類，2022-2032 年

  • 北美洲
    • 美國
      • 依最終用途細分，2022-2032 年
      • 按配銷通路細分，2022-2032 年
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第 8 章：競爭情報

  • 重點公司 SWOT 分析
    • Charlotte's Web Holdings, Inc.
    • Aurora Cannabis Inc.
    • Canopy Growth Corporation
  • 頂級市場策略
  • 公司簡介
    • Charlotte's Web Holdings, Inc.
      • 關鍵訊息
      • 概述
      • 財務（視數據可用性而定）
      • 產品概要
      • 市場策略
    • Aurora Cannabis Inc.
    • Canopy Growth Corporation
    • CV Sciences, Inc.
    • Elixinol Global Limited
    • Medical Marijuana, Inc.
    • HempMeds
    • Endoca
    • Joy Organics
    • Green Roads
    • CBDistillery
    • Medterra CBD
    • NuLeaf Naturals, LLC
    • Veritas Farms, Inc.
    • PharmaHemp doo

第9章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
簡介目錄

Global Hemp CBD Market is valued approximately at USD 3.91 billion in 2023 and is anticipated to grow with an impressive CAGR of more than 18.59% over the forecast period 2024-2032. Cannabidiol (CBD), a non-psychoactive compound derived from hemp, has emerged as one of the most disruptive and transformative forces in the wellness, pharmaceutical, and nutraceutical markets. Its surge in popularity can be traced to its wide-ranging therapeutic benefits-ranging from pain management and anti-inflammatory properties to its efficacy in treating anxiety and insomnia-making it a favored alternative across multiple consumer demographics. As regulatory landscapes evolve and societal attitudes toward cannabis derivatives soften, hemp-derived CBD products have secured a foothold across mainstream retail channels, driving demand across both developed and emerging economies.

The upward momentum in the hemp CBD market has been reinforced by several converging macroeconomic and behavioral shifts. Increasing awareness regarding the benefits of plant-based therapies, coupled with a rising inclination toward natural health remedies, has amplified consumer interest. Moreover, the legalization of hemp cultivation in various jurisdictions has galvanized the supply chain and opened floodgates for innovation across product categories including tinctures, topicals, edibles, and personal care items. However, the market continues to wrestle with complexities such as inconsistent regulatory frameworks, lack of standardized dosing protocols, and quality control challenges. Even so, increasing R&D investments and strategic collaborations among manufacturers, research institutions, and government bodies are actively addressing these barriers, paving the way for scalable, compliant growth.

Consumer preferences are becoming more sophisticated, pushing brands to diversify their product offerings and enhance delivery formats. From water-soluble CBD beverages to nano-emulsified formulations with faster absorption rates, the innovation race is redefining competitive advantage in this space. Additionally, there is a marked shift toward functional wellness, with CBD-infused products now integrated into daily routines such as skincare regimens, nutritional supplementation, and even pet care. Distribution channels have evolved in tandem, with e-commerce platforms playing a pivotal role in expanding reach, while brick-and-mortar outlets like pharmacies, wellness stores, and specialty boutiques are bolstering consumer trust through in-store education and product sampling.

North America dominates the global hemp CBD market, owing to early regulatory liberalization, high consumer awareness, and a well-established supply chain infrastructure. The United States continues to lead in innovation and adoption, spurred by a robust ecosystem of startups, legacy health brands, and aggressive marketing campaigns. Europe follows as a close contender, supported by a health-conscious population, progressive regulatory changes, and increased spending on alternative medicine. Asia Pacific, though relatively nascent, is witnessing accelerating growth due to expanding legalization frameworks, rising disposable income, and evolving consumer lifestyles in key markets like China, India, and Japan. Latin America and the Middle East & Africa are gradually emerging as opportunity-rich zones, particularly as governments initiate cannabis reform and health & wellness awareness improves.

Major market player included in this report are:

  • Charlotte's Web Holdings, Inc.
  • Aurora Cannabis Inc.
  • Canopy Growth Corporation
  • CV Sciences, Inc.
  • Elixinol Global Limited
  • Medical Marijuana, Inc.
  • HempMeds
  • Endoca
  • Joy Organics
  • Green Roads
  • CBDistillery
  • Medterra CBD
  • NuLeaf Naturals, LLC
  • Veritas Farms, Inc.
  • PharmaHemp d.o.o.

The detailed segments and sub-segment of the market are explained below:

By End Use

  • Personal Use
  • Medical Use
  • Wellness and Cosmetics
  • Food and Beverage
  • Others

By Distribution Channel

  • Online
  • Offline

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical Year - 2022
  • Base Year - 2023
  • Forecast Period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Hemp CBD Market Executive Summary

  • 1.1. Global Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By End Use
    • 1.3.2. By Distribution Channel
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Hemp CBD Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply-Side Analysis
      • 2.3.3.1. Cultivation & Extraction Capacity
      • 2.3.3.2. Processing Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Producer Perspective)
    • 2.3.4. Demand-Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Consumer Awareness & Acceptance
      • 2.3.4.3. Technological Advancements in Formulation
      • 2.3.4.4. Health & Wellness Trends
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Hemp CBD Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Widening therapeutic applications and wellness adoption
    • 3.1.2. Legalization and regulatory liberalization of hemp cultivation
    • 3.1.3. Surge in demand for natural, plant-based health solutions
  • 3.2. Market Challenges
    • 3.2.1. Inconsistent regulatory frameworks across regions
    • 3.2.2. Quality control and lack of standardized dosing
    • 3.2.3. Supply chain complexities and raw material variability
  • 3.3. Market Opportunities
    • 3.3.1. Innovation in delivery formats (nano-emulsions, water-soluble blends)
    • 3.3.2. E-commerce and direct-to-consumer channel expansion
    • 3.3.3. Growth potential in emerging markets

Chapter 4. Global Hemp CBD Market Industry Analysis

  • 4.1. Porter's Five Forces Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's Five Forces
    • 4.1.7. Five Forces Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunities
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Hemp CBD Market Size & Forecasts by End Use, 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Revenue Trend Analysis by End Use, 2022 & 2032 (USD Million/Billion)
    • 5.2.1. Personal Use
    • 5.2.2. Medical Use
    • 5.2.3. Wellness and Cosmetics
    • 5.2.4. Food and Beverage
    • 5.2.5. Others

Chapter 6. Global Hemp CBD Market Size & Forecasts by Distribution Channel, 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Revenue Trend Analysis by Distribution Channel, 2022 & 2032 (USD Million/Billion)
    • 6.2.1. Online
    • 6.2.2. Offline

Chapter 7. Global Hemp CBD Market Size & Forecasts by Region, 2022-2032

  • 7.1. North America
    • 7.1.1. U.S.
      • 7.1.1.1. By End Use breakdown, 2022-2032
      • 7.1.1.2. By Distribution Channel breakdown, 2022-2032
    • 7.1.2. Canada
  • 7.2. Europe
    • 7.2.1. UK
    • 7.2.2. Germany
    • 7.2.3. France
    • 7.2.4. Spain
    • 7.2.5. Italy
    • 7.2.6. Rest of Europe
  • 7.3. Asia Pacific
    • 7.3.1. China
    • 7.3.2. India
    • 7.3.3. Japan
    • 7.3.4. Australia
    • 7.3.5. South Korea
    • 7.3.6. Rest of Asia Pacific
  • 7.4. Latin America
    • 7.4.1. Brazil
    • 7.4.2. Mexico
    • 7.4.3. Rest of Latin America
  • 7.5. Middle East & Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. South Africa
    • 7.5.3. Rest of Middle East & Africa

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Charlotte's Web Holdings, Inc.
    • 8.1.2. Aurora Cannabis Inc.
    • 8.1.3. Canopy Growth Corporation
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Charlotte's Web Holdings, Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. Aurora Cannabis Inc.
    • 8.3.3. Canopy Growth Corporation
    • 8.3.4. CV Sciences, Inc.
    • 8.3.5. Elixinol Global Limited
    • 8.3.6. Medical Marijuana, Inc.
    • 8.3.7. HempMeds
    • 8.3.8. Endoca
    • 8.3.9. Joy Organics
    • 8.3.10. Green Roads
    • 8.3.11. CBDistillery
    • 8.3.12. Medterra CBD
    • 8.3.13. NuLeaf Naturals, LLC
    • 8.3.14. Veritas Farms, Inc.
    • 8.3.15. PharmaHemp d.o.o.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes